X0306 4 2018-12-11 0 0001682852 Moderna, Inc. MRNA 0001760669 Hoge Stephen C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 0 1 0 0 President Common Stock 2018-12-11 4 C 0 458 A 2096530 D Common Stock 4116 I By Valhalla, LLC Series E Preferred Stock 2018-12-11 4 C 0 458 D Common Stock 458 0 D The Series E Preferred Stock (the "Preferred Stock") converted into Common Stock based on an applicable conversion ratio of 0.45859 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. /s/ Jeffrey Cerio, as Attorney-in-Fact 2018-12-13